Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Yu-ying Shi"'
Autor:
Yu-Ying Shi, Gang Fan, Ruirong Tan, Shan Li, Hua-Bing Sun, Rui Li, Mengni Yang, Shanshan Gao, Miao Liu, Meng-Yuan Dai
Publikováno v:
Cell Death and Disease, Vol 15, Iss 9, Pp 1-13 (2024)
Abstract The current selection of ligands for both proteins of interest (POI) and E3 ubiquitin ligase significantly restricts the scope of targeted protein degradation (TPD) technologies. This study introduces cell-penetrating peptide-induced chimera
Externí odkaz:
https://doaj.org/article/aac14e898bd84fae9a32372bac3d450d
Autor:
Yu-Ying Shi, Si-Yuan Liao, Qiao-Feng Wang, Xin-Yun Xu, Xiao-Yun Wang, Xin-Yin Gu, You-Gen Hu, Peng-Li Zhu, Rong Sun, Yan-Jun Wan
Publikováno v:
Nano-Micro Letters, Vol 16, Iss 1, Pp 1-14 (2024)
Highlights A strategy based on metal-organic decomposition is proposed to enhance the tube-tube interactions of carbon nanotubes (CNTs). The robust tube-tube interactions of CNTs enhance both EMI shielding performance and mechanical properties of CNT
Externí odkaz:
https://doaj.org/article/5fc34887c05f40909f652bb20a03b2df
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionOur previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. However, this degradation is not a sustained and efficien
Externí odkaz:
https://doaj.org/article/b0e3dff281a74a40ae2f080b55e7f559
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/6dac064c155a425e9b912046303a8319
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionImmune checkpoint inhibitors (ICIs) are monoclonal antibodies that target immune checkpoints that suppress immune cell activity. Low efficiency and high resistance are currently the main barriers to their clinical application. As a repres
Externí odkaz:
https://doaj.org/article/e6455c1ab77442e1b22d6f0afdf33318
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Immune checkpoint inhibitors have made significant progress in the treatment of various cancers. However, due to the low ICI responsive rate for the gynecologic cancer, ICI two-drug combination therapy tends to be a predominant way for clinical treat
Externí odkaz:
https://doaj.org/article/b0fb696dfccf4c1cb0f8b39114485a55
Autor:
Li-Hua Zheng, Ao-Zhe Zhang, Yu-Ying Shi, Xin Li, Lan-Si Jia, Cong-Cong Zhi, Qiu-Xiang Yu, Wen Zhang, Yan-Jun Liu, Luan Wang, Dan Xiao, Chen Wang
Publikováno v:
Chinese Medical Journal, Vol 131, Iss 9, Pp 1034-1037 (2018)
Background: Several studies have investigated the association between smoking and anal abscess and anal fistula (AA/F) diseases. However, the relationship between cigarette smoking and AA/F remains unclear. This study sought to assess the role of smo
Externí odkaz:
https://doaj.org/article/15365344ec864083892ae54b686fc4c8
Autor:
Xiao‐Yun Wang, Si‐Yuan Liao, Hai‐Peng Huang, Qiao‐Feng Wang, Yu‐Ying Shi, Peng‐Li Zhu, You‐Gen Hu, Rong Sun, Yan‐Jun Wan
Publikováno v:
Small Methods. 7
Autor:
Si-Yuan Liao, Xiao-Yun Wang, Hai-Peng Huang, Yu-Ying Shi, Qiao-Feng Wang, You-Gen Hu, Peng-Li Zhu, Rong Sun, Ching-Ping Wong, Yan-Jun Wan
Publikováno v:
Chemical Engineering Journal. 464:142596
Publikováno v:
Cancer Management and Research
Yuying Shi,1– 3,* Mengyuan Dai,1– 3,* Yaxing Zhang,1– 3 Yuwen Qi,1– 3 Zhen Li,1– 3 Hongbing Cai1– 3 1Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China; 2Hubei Key Labor